# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-035062
Filing Date
2017-06-30
Accepted
2017-06-30 07:01:58
Documents
7
Period of Report
2017-08-01
Effectiveness Date
2017-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | v469499_def14a.htm | DEF 14A | 717442
2 | GRAPHIC | pg38img1_def14a.jpg | GRAPHIC | 55221
3 | GRAPHIC | pg3img1_def14a.jpg | GRAPHIC | 4054
4 | GRAPHIC | pg4img1_def14a.jpg | GRAPHIC | 1758
5 | GRAPHIC | pg61img1_def14a.jpg | GRAPHIC | 3127
6 | GRAPHIC | proxy1_def14a.jpg | GRAPHIC | 251347
7 | GRAPHIC | proxy2_def14a.jpg | GRAPHIC | 227742
| Complete submission text file | 0001144204-17-035062.txt |  | 1467628

Mailing Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591
Business Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591 (914) 524-6800
Prestige Brands Holdings, Inc. (Filer) CIK: 0001295947 (see all company filings)

EIN.: 201297589 | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-32433 | Film No.: 17940311
SIC: 2834 Pharmaceutical Preparations